Bg pattern

AQUIPTA 60 mg TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AQUIPTA 60 mg TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

AQUIPTA 10 mg comprimidos

AQUIPTA 60 mg comprimidos

atogepant

Este medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Puede contribuir comunicando los efectos adversos que pudiera usted tener. La parte final de la sección 4 incluye información sobre cómo comunicar estos efectos adversos.

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto

  1. Qué es AQUIPTA y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar AQUIPTA
  3. Cómo tomar AQUIPTA
  4. Posibles efectos adversos
  5. Conservación de AQUIPTA
  6. Contenido del envase e información adicional

1. Qué es AQUIPTA y para qué se utiliza

AQUIPTA contiene el principio activo atogepant. AQUIPTA se utiliza para prevenir la migraña en adultos que padecen al menos 4 días de migraña al mes.

AQUIPTA se cree que bloquea la actividad de la familia de receptores de la calcitonina/péptido relacionado con el gen de la calcitonina (CGRP), que se han relacionado con la migraña.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar AQUIPTA

No tome AQUIPTA

  • si es alérgico a atogepant o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).

Advertencias y precauciones

Deje de tomar AQUIPTA e informe a su médico inmediatamente si experimenta algún síntoma de una reacción alérgica como:

  • dificultad para respirar
  • hinchazón de la cara
  • erupción, picazón o urticaria

Algunos de estos síntomas pueden ocurrir dentro de las 24 horas posteriores al primer uso. A veces pueden ocurrir varios días después de tomar AQUIPTA.

Consulte a su médico, farmacéutico o enfermero antes de empezar a tomar AQUIPTA si tiene problemas hepáticos graves.

Niños y adolescentes

No administre este medicamento a niños o adolescentes menores de 18 años de edad, ya que no se ha estudiado el uso de AQUIPTA en este grupo de edad.

Otros medicamentos y AQUIPTA

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento. Algunos medicamentos pueden aumentar el riesgo de presentar efectos adversos (ver sección 4).

La siguiente lista contiene ejemplos de medicamentos que pueden requerir que su médico le reduzca la dosis de AQUIPTA:

  • ketoconazol, itraconazol, claritromicina, rifampicina (medicamentos utilizados para tratar infecciones por hongos o bacterias);
  • ritonavir (medicamento utilizado para tratar el VIH);
  • ciclosporina (medicamento que afecta a su sistema inmunológico).

Embarazo, lactancia y fertilidad

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico antes de utilizar este medicamento.

Si está embarazada, no debe tomar AQUIPTA. Si es mujer y podría quedarse embarazada, debe utilizar métodos anticonceptivos adecuados durante el tratamiento con AQUIPTA.

Si está en periodo de lactancia o tiene intención de dar el pecho, no debe tomar AQUIPTA. Usted y su médico deben decidir si va a dar el pecho o tomar AQUIPTA.

Conducción y uso de máquinas

AQUIPTA puede hacer que se sienta somnoliento. No conduzca ni utilice máquinas si le afecta.

AQUIPTA contiene sodio

AQUIPTA 10 mg comprimidos

Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.

AQUIPTA 60 mg comprimidos

Este medicamento contiene 31,5 mg de sodio (componente principal de la sal de mesa/para cocinar) en cada comprimido. Esto equivale al 1,6 % de la ingesta diaria máxima de sodio recomendada para un adulto.

3. Cómo tomar AQUIPTA

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Cuánto tomar

La dosis recomendada es de 60 mg de atogepant una vez al día. Su médico puede indicarle que tome una dosis menor si:

  • está tomando otros medicamentos (mencionados en la sección 2);
  • tiene problemas renales graves o está en diálisis.

Cómo tomar

AQUIPTA se administra por vía oral. No parta, triture, mastique ni rompa el comprimido antes de tragarlo. Los comprimidos se pueden tomar con o sin alimentos.

Si toma más AQUIPTA del que debe

Si toma más comprimidos de los que debe, consulte a su médico. Puede presentar algunos de los efectos adversos mencionados en la sección 4.

Si olvidó tomar AQUIPTA

  • Si olvida una dosis, tómela en cuanto se acuerde.
  • Si se olvida durante un día entero, se debe saltar la dosis olvidada y tomar una dosis de la forma habitual al día siguiente.
  • No tome una dosis doble para compensar las dosis olvidadas.

Si interrumpe el tratamiento con AQUIPTA

No deje de tomar AQUIPTA sin consultarlo antes con su médico. Los síntomas pueden aparecer de nuevo si interrumpe el tratamiento.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Efectos secundarios graves

Deje de tomar AQUIPTA y contacte con su médico inmediatamente si tiene alguno de los siguientes síntomas, que pueden ser parte de una reacción alérgica grave:

  • dificultad para respirar
  • hinchazón de la cara
  • erupción, picazón o urticaria

Otros efectos secundarios

Informe a su médico si observa alguno de los siguientes efectos adversos:

Frecuentes(pueden afectar hasta 1 de cada 10 personas):

  • náuseas (ganas de vomitar);
  • estreñimiento;
  • fatiga (cansancio);
  • somnolencia (tendencia al sueño);
  • apetito disminuido;
  • pérdida de peso.

Poco frecuentes(pueden afectar hasta 1 de cada 100 personas):

  • aumento de los niveles de las enzimas hepáticas.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del sistema nacional de notificación incluido en el Apéndice V. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de AQUIPTA

Mantener este medicamento fuera de la vista y del alcance de los niños.

No utilice este medicamento después de la fecha de caducidad que aparece en la caja y en el blíster después de EXP. La fecha de caducidad es el último día del mes que se indica.

Este medicamento no requiere condiciones especiales de conservación.

Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de AQUIPTA

AQUIPTA 10 mg comprimidos

  • El principio activo es atogepant. Cada comprimido contiene 10 mg de atogepant.
  • Los demás componentes son: copolímero de polivinilpirrolidona/acetato de vinilo, succinato de polietilenglicol y vitamina E, manitol, celulosa microcristalina, cloruro de sodio, croscarmelosa sódica, dióxido de silicio coloidal y estearil fumarato de sodio (ver sección 2).

AQUIPTA 60 mg comprimidos

  • El principio activo es atogepant. Cada comprimido contiene 60 mg de atogepant.
  • Los demás componentes son: copolímero de polivinilpirrolidona/acetato de vinilo, succinato de polietilenglicol y vitamina E, manitol, celulosa microcristalina, cloruro de sodio, croscarmelosa sódica, dióxido de silicio coloidal y estearil fumarato de sodio (ver sección 2).

Aspecto del producto y contenido del envase

AQUIPTA 10 mg comprimidos

El comprimido de 10 mg de AQUIPTA es un comprimido biconvexo, redondo, de color blanco a blanquecino, con la inscripción “A” y “10” en una cara. Está disponible en envases que contienen 28 o 98 comprimidos.

AQUIPTA 60 mg comprimidos

El comprimido de 60 mg de AQUIPTA es un comprimido biconvexo, ovalado, de color blanco a blanquecino, con la inscripción “A60” en una cara. Está disponible en envases que contienen 28 o 98 comprimidos.

Puede que solamente estén comercializados algunos tamaños de envases.

Titular de la autorización de comercialización

AbbVie Deutschland GmbH & Co. KG

Knollstrasse

67061 Ludwigshafen

Alemania

Responsable de la fabricación

AbbVie S.r.l

S.R. 148 Pontina Km 52 Snc

Campoverde di Aprilia, Latina 04011

Italia

Pueden solicitar más información respecto a este medicamento dirigiéndose al representante local del titular de la autorización de comercialización:

België/Belgique/Belgien

AbbVie SA

Tél/Tel: +32 10 477811

Lietuva

AbbVie UAB

Tel: +370 5 205 3023

Texto en idioma búlgaro con información de contacto incluyendo nombre de empresa y número telefónico

Luxembourg/Luxemburg

AbbVie SA

Belgique/Belgien

Tél/Tel: +32 10 477811

Ceská republika

AbbVie s.r.o.

Tel: +420 233 098 111

Magyarország

AbbVie Kft.

Tel.:+36 1 455 8600

Danmark

AbbVie A/S

Tlf: +45 72 30-20-28

Malta

Vivian Corporation Ltd.

Tel: +356 27780331

Deutschland

AbbVie Deutschland GmbH & Co. KG

Tel: 00800 222843 33 (gebührenfrei)

Tel: +49 (0) 611 / 1720-0

Nederland

AbbVie B.V.

Tel: +31 (0)88 322 2843

Eesti

AbbVie OÜ

Tel: +372 623 1011

Norge

AbbVie AS

Tlf: +47 67 81 80 00

Ελλ?δα

AbbVie ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε.

Τηλ: +30 214 4165 555

Österreich

AbbVie GmbH

Tel: +43 1 20589-0

España

AbbVie Spain, S.L.U.

Tel: +34 91 384 09 10

Polska

AbbVie Sp. z o.o.

Tel.: +48 22 372 78 00

France

AbbVie

Tél: +33 (0) 1 45 60 13 00

Portugal

AbbVie, Lda.

Tel: +351 (0)21 1908400

Hrvatska

AbbVie d.o.o.

Tel + 385 (0)1 5625 501

România

AbbVie S.R.L.

Tel: +40 21 529 30 35

Ireland

AbbVie Limited

Tel: +353 (0)1 4287900

Slovenija

AbbVie Biofarmacevtska družba d.o.o.

Tel: +386 (1)32 08 060

Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

AbbVie s.r.o.

Tel: +421 2 5050 0777

Italia

AbbVie S.r.l.

Tel: +39 06 928921

Suomi/Finland

AbbVie Oy

Puh/Tel: +358 (0)10 2411 200

Κúπρος

Lifepharma (Z.A.M.) Ltd

Τηλ.: +357 22 34 74 40

Sverige

AbbVie AB

Tel: +46 (0)8 684 44 600

Latvija

AbbVie SIA

Tel: +371 67605000

Fecha de la última revisión de este prospecto:

Otras fuentes de información

La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos: http://www.ema.europa.eu/.

Para escuchar o solicitar una copia de este prospecto en, o escucharlo en , póngase en contacto con el representante local del titular de la autorización de comercialización.

Online doctors for AQUIPTA 60 mg TABLETS

Discuss questions about AQUIPTA 60 mg TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

5.0 (97)
Doctor

Jorge Correa Bellido

General medicine 7 years exp.

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

5.0 (197)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

5.0 (1225)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

Get AQUIPTA 60 mg TABLETS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for AQUIPTA 60 mg TABLETS?

AQUIPTA 60 mg TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in AQUIPTA 60 mg TABLETS?

The active ingredient in AQUIPTA 60 mg TABLETS is atogepant. This information helps identify medicines with the same composition but different brand names.

Who manufactures AQUIPTA 60 mg TABLETS?

AQUIPTA 60 mg TABLETS is manufactured by Abbvie Deutschland Gmbh & Co. Kg. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of AQUIPTA 60 mg TABLETS online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AQUIPTA 60 mg TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy AQUIPTA 60 mg TABLETS in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy AQUIPTA 60 mg TABLETS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to AQUIPTA 60 mg TABLETS?

Other medicines with the same active substance (atogepant) include AQUIPTA 10 mg TABLETS, AIMOVIG 140 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AIMOVIG 70 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media